Portal de Las Torres de Cotillas
www.portaldelastorresdecotillas.com
The company makes this decision encouraged by the support and facilities driven by the regional government, through the Info
The Minister of Universities and Research Company, Salvador Marín, accompanied by the head of Health, María Ángeles Palacios, announced today that the company Grifols pharmaceutical company will invest 16.6 million euros to build and equip a new plant in region.
The new infrastructure will house a production line of high-tech serum bags polypropylene (PP), which replaced the PVC and will result in environmental improvements and drug compatibility.
Since the installation of Grifols in the Region, in 1991, until last year, the company has invested more than 18 million "of which over 1.4 are from the aid granted by the regional government, through the Institute Development of the Region of Murcia, through the Plan for Attracting Investment in the Region of Murcia, "Marin recalled.
According to the pharmaceutical, this investment responds, inter alia, to support programs promoted by the regional government, through the Info This will improve the production process with the use of new materials and industrial technologies and information for increase productivity.
The new plant, which will be appended to the already existing Cotillas Towers, will expand by 100 100 the ability to manufacture its products, and will also have facilities prepared for the new product portfolio R & D and manufacturing to third parties.
The adviser said that "Grifols is an example and reference for the pharmaceutical sector for its business model and the continuity of its activity during vertebrate 60 years in research, without neglecting some ethical premises that put the health of the patient any other interest. "
For his part, Parker stressed the importance for patients in the region the presence of these laboratories, as "the blood that makes Grifols plasma obtained from the Regional Center of Blood Donation and, therefore, of gifts our region. "
He stressed that "the Health Service of Murcia has an agreement with Grifols since 2007 for the supply of blood products to health facilities in the region."
The Minister said that the agreement "has improved the control of the source of plasma used in the manufacture of blood products and drugs, therefore, has enhanced the safety of their use."
More IV fluids and blood bags
The new plant will begin construction in a month and be completed in two years, will expand its current production capacity from 20 to 40 million units of intravenous fluids in the year 2013 to meet the needs of sales growth.
In particular, blood bags production will reach 100 by 100 more than current production, which will increase production from 4.7 to 9.5 million units.
Investment in new welding line, dosing and intravenous solutions in closed polypropylene serum improve the overall process in parenteral solutions, ie, productivity, energy efficiency and water consumption and raw materials, through the use of technology more advanced.
Grifols
Grifols has a direct presence in 18 countries through its subsidiaries, but its products are distributed in over 90 countries.
In Spain has two production plants for pharmaceutical products in Barcelona and Murcia.
Plant Cotillas Towers currently has 300 employees, and was the first plant to which he was awarded the 'CE' marking in Spain.
Source: CARM
Privacy policy
- Legal notice
- Cookies